| Characteristic . | Score range of measure . | Value . | n . |
|---|---|---|---|
| Age, mean (s.d.), years | – | 61.6 (12.8) | 88 |
| Male sex, n (%) | – | 83 (94.3) | 88 |
| BMI, mean (s.d), kg/m2 | – | 29.1 (4.1) | 86 |
| Systolic blood pressure, mean (s.d.), mmHg | 0–999 | 143.3 (22.9) | 79 |
| Diastolic blood pressure, mean (s.d.), mmHg | 0–999 | 85.2 (14.5) | 80 |
| SUA, median (Q1, Q3), mmol/l | 0–9 | 0.51 (0.44, 0.59) | 82 |
| CRP, median (Q1, Q3), mg/l | 0–999 | 15.0 (6.0, 32.0) | 82 |
| GAIS, median (Q1, Q3) | 1–5 | 3.67 (3, 4) | 76 |
| 5-point rating scale pain, median (Q1, Q3) | 1–5 | 4 (3, 4) | 76 |
| 5-point rating scale tenderness, median (Q1, Q3) | 1–5 | 4 (3, 4) | 76 |
| 5-point rating scale swelling, median (Q1, Q3) | 1–5 | 3 (3, 4) | 76 |
| NRS pain, mean (s.d.) | 0–10 | 6.47 (1.70) | 76 |
| Gout classificationa, n (%) | |||
| Monoarticular | – | 53 (60.2) | 88 |
| Oligoarticular | – | 28 (31.8) | 88 |
| Polyarticular | – | 7 (8.0) | 88 |
| Number of gout attacks in previous ≤12 months, median (Q1, Q3) | 0–999 | 3.0 (1.0, 4.0) | 88 |
| Intermittent gout, n (%)b | – | 71 (80.7) | 88 |
| Comorbidities, n (%) | |||
| Diabetes mellitus | – | 8 (15.1) | 53 |
| Hypertension | – | 27 (50.9) | 53 |
| Cardiovascular disease | – | 29 (54.7) | 53 |
| Renal disorders | – | 5 (9.4) | 53 |
| Musculoskeletal diseasec | – | 10 (18.9) | 53 |
| Gastrointestinal disorders | – | 10 (18.9) | 53 |
| Neurological disorders | – | 4 (7.5) | 53 |
| Characteristic . | Score range of measure . | Value . | n . |
|---|---|---|---|
| Age, mean (s.d.), years | – | 61.6 (12.8) | 88 |
| Male sex, n (%) | – | 83 (94.3) | 88 |
| BMI, mean (s.d), kg/m2 | – | 29.1 (4.1) | 86 |
| Systolic blood pressure, mean (s.d.), mmHg | 0–999 | 143.3 (22.9) | 79 |
| Diastolic blood pressure, mean (s.d.), mmHg | 0–999 | 85.2 (14.5) | 80 |
| SUA, median (Q1, Q3), mmol/l | 0–9 | 0.51 (0.44, 0.59) | 82 |
| CRP, median (Q1, Q3), mg/l | 0–999 | 15.0 (6.0, 32.0) | 82 |
| GAIS, median (Q1, Q3) | 1–5 | 3.67 (3, 4) | 76 |
| 5-point rating scale pain, median (Q1, Q3) | 1–5 | 4 (3, 4) | 76 |
| 5-point rating scale tenderness, median (Q1, Q3) | 1–5 | 4 (3, 4) | 76 |
| 5-point rating scale swelling, median (Q1, Q3) | 1–5 | 3 (3, 4) | 76 |
| NRS pain, mean (s.d.) | 0–10 | 6.47 (1.70) | 76 |
| Gout classificationa, n (%) | |||
| Monoarticular | – | 53 (60.2) | 88 |
| Oligoarticular | – | 28 (31.8) | 88 |
| Polyarticular | – | 7 (8.0) | 88 |
| Number of gout attacks in previous ≤12 months, median (Q1, Q3) | 0–999 | 3.0 (1.0, 4.0) | 88 |
| Intermittent gout, n (%)b | – | 71 (80.7) | 88 |
| Comorbidities, n (%) | |||
| Diabetes mellitus | – | 8 (15.1) | 53 |
| Hypertension | – | 27 (50.9) | 53 |
| Cardiovascular disease | – | 29 (54.7) | 53 |
| Renal disorders | – | 5 (9.4) | 53 |
| Musculoskeletal diseasec | – | 10 (18.9) | 53 |
| Gastrointestinal disorders | – | 10 (18.9) | 53 |
| Neurological disorders | – | 4 (7.5) | 53 |
Monoarticular implies one joint has been affected by gout; oligoarticular, more than one but fewer than five joints have been affected by gout; polyarticular, five or more joints have been affected by gout.
Compared with patients having chronic gout.
Diseases other than gout. SUA: serum urate acid; GAIS: Gout Attack Intensity Score; NRS: numeric rating scale; n: total number of patients; Q1, Q3: first and third quartile respectively.
| Characteristic . | Score range of measure . | Value . | n . |
|---|---|---|---|
| Age, mean (s.d.), years | – | 61.6 (12.8) | 88 |
| Male sex, n (%) | – | 83 (94.3) | 88 |
| BMI, mean (s.d), kg/m2 | – | 29.1 (4.1) | 86 |
| Systolic blood pressure, mean (s.d.), mmHg | 0–999 | 143.3 (22.9) | 79 |
| Diastolic blood pressure, mean (s.d.), mmHg | 0–999 | 85.2 (14.5) | 80 |
| SUA, median (Q1, Q3), mmol/l | 0–9 | 0.51 (0.44, 0.59) | 82 |
| CRP, median (Q1, Q3), mg/l | 0–999 | 15.0 (6.0, 32.0) | 82 |
| GAIS, median (Q1, Q3) | 1–5 | 3.67 (3, 4) | 76 |
| 5-point rating scale pain, median (Q1, Q3) | 1–5 | 4 (3, 4) | 76 |
| 5-point rating scale tenderness, median (Q1, Q3) | 1–5 | 4 (3, 4) | 76 |
| 5-point rating scale swelling, median (Q1, Q3) | 1–5 | 3 (3, 4) | 76 |
| NRS pain, mean (s.d.) | 0–10 | 6.47 (1.70) | 76 |
| Gout classificationa, n (%) | |||
| Monoarticular | – | 53 (60.2) | 88 |
| Oligoarticular | – | 28 (31.8) | 88 |
| Polyarticular | – | 7 (8.0) | 88 |
| Number of gout attacks in previous ≤12 months, median (Q1, Q3) | 0–999 | 3.0 (1.0, 4.0) | 88 |
| Intermittent gout, n (%)b | – | 71 (80.7) | 88 |
| Comorbidities, n (%) | |||
| Diabetes mellitus | – | 8 (15.1) | 53 |
| Hypertension | – | 27 (50.9) | 53 |
| Cardiovascular disease | – | 29 (54.7) | 53 |
| Renal disorders | – | 5 (9.4) | 53 |
| Musculoskeletal diseasec | – | 10 (18.9) | 53 |
| Gastrointestinal disorders | – | 10 (18.9) | 53 |
| Neurological disorders | – | 4 (7.5) | 53 |
| Characteristic . | Score range of measure . | Value . | n . |
|---|---|---|---|
| Age, mean (s.d.), years | – | 61.6 (12.8) | 88 |
| Male sex, n (%) | – | 83 (94.3) | 88 |
| BMI, mean (s.d), kg/m2 | – | 29.1 (4.1) | 86 |
| Systolic blood pressure, mean (s.d.), mmHg | 0–999 | 143.3 (22.9) | 79 |
| Diastolic blood pressure, mean (s.d.), mmHg | 0–999 | 85.2 (14.5) | 80 |
| SUA, median (Q1, Q3), mmol/l | 0–9 | 0.51 (0.44, 0.59) | 82 |
| CRP, median (Q1, Q3), mg/l | 0–999 | 15.0 (6.0, 32.0) | 82 |
| GAIS, median (Q1, Q3) | 1–5 | 3.67 (3, 4) | 76 |
| 5-point rating scale pain, median (Q1, Q3) | 1–5 | 4 (3, 4) | 76 |
| 5-point rating scale tenderness, median (Q1, Q3) | 1–5 | 4 (3, 4) | 76 |
| 5-point rating scale swelling, median (Q1, Q3) | 1–5 | 3 (3, 4) | 76 |
| NRS pain, mean (s.d.) | 0–10 | 6.47 (1.70) | 76 |
| Gout classificationa, n (%) | |||
| Monoarticular | – | 53 (60.2) | 88 |
| Oligoarticular | – | 28 (31.8) | 88 |
| Polyarticular | – | 7 (8.0) | 88 |
| Number of gout attacks in previous ≤12 months, median (Q1, Q3) | 0–999 | 3.0 (1.0, 4.0) | 88 |
| Intermittent gout, n (%)b | – | 71 (80.7) | 88 |
| Comorbidities, n (%) | |||
| Diabetes mellitus | – | 8 (15.1) | 53 |
| Hypertension | – | 27 (50.9) | 53 |
| Cardiovascular disease | – | 29 (54.7) | 53 |
| Renal disorders | – | 5 (9.4) | 53 |
| Musculoskeletal diseasec | – | 10 (18.9) | 53 |
| Gastrointestinal disorders | – | 10 (18.9) | 53 |
| Neurological disorders | – | 4 (7.5) | 53 |
Monoarticular implies one joint has been affected by gout; oligoarticular, more than one but fewer than five joints have been affected by gout; polyarticular, five or more joints have been affected by gout.
Compared with patients having chronic gout.
Diseases other than gout. SUA: serum urate acid; GAIS: Gout Attack Intensity Score; NRS: numeric rating scale; n: total number of patients; Q1, Q3: first and third quartile respectively.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
